Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)

Regenxbio's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at -$218.2 million for Q4 2025.

• On a quarterly basis, Change in Acquisitions & Divestments rose 6.22% year-over-year to -$218.2 million in Q4 2025; TTM through Dec 2025 was $62000.0, a 98.93% decrease from a year earlier, with the FY2025 full-year figure at $62000.0, down 98.93% from the prior year.
• Change in Acquisitions & Divestments eased to -$218.2 million in Q4 2025 per RGNX's latest filing, from $82.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $283.5 million in Q4 2023 and bottomed at -$232.7 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $57.7 million (2021), against an average of $33.2 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 542.39% in 2023; the steepest drop was 340.61% in 2023.
• Year by year, Change in Acquisitions & Divestments stood at $33.7 million in 2021, then soared by 30.96% to $44.1 million in 2022, then soared by 542.39% to $283.5 million in 2023, then slumped by 182.06% to -$232.7 million in 2024, then rose by 6.22% to -$218.2 million in 2025.
• Per Business Quant, the three latest RGNX Change in Acquisitions & Divestments figures stand at -$218.2 million (Q4 2025), $82.2 million (Q3 2025), and $71.1 million (Q2 2025).